Karin E. Smedby
- Co-authors
- Eva BaecklundJohan AsklingRichard RosenquistLesley‐Ann SuttonXavier MarietteMads MelbyeH WilczekEllen T. Chang
- Topics
- Lymphoma Diagnosis and Treatment (11 papers)Chronic Lymphocytic Leukemia Research (4 papers)Cancer Risks and Factors (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaJNCI Journal of the National Cancer InstituteAmerican Journal of Epidemiology
- Partner nations
- SwedenDenmarkUnited States
In The Last Decade
Karin E. Smedby
18 papers receiving 531 citations
Peers
Comparison fields: 5 of 61
- Pathology and Forensic Medicine 249
- Oncology 217
- Genetics 164
- Immunology 106
- Rheumatology 65
Countries citing papers authored by Karin E. Smedby
This map shows the geographic impact of Karin E. Smedby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin E. Smedby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin E. Smedby more than expected).
Fields of papers citing papers by Karin E. Smedby
This network shows the impact of papers produced by Karin E. Smedby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin E. Smedby. The network helps show where Karin E. Smedby may publish in the future.
Co-authorship network of co-authors of Karin E. Smedby
This figure shows the co-authorship network connecting the top 25 collaborators of Karin E. Smedby. A scholar is included among the top collaborators of Karin E. Smedby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin E. Smedby. Karin E. Smedby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | High Expression Of Programmed Cell Death Receptor 1 In The Tumor Microenvironment Is Associated With Inferior Event Free Survival In Classical Hodgkin Lymphoma | 4 |
| 7 | 6 | |
| 8 | 18 | |
| 9 | 22 | |
| 10 | 26 | |
| 11 | 12 | |
| 12 | 21 | |
| 13 | 48 | |
| 14 | 136 | |
| 15 | 30 | |
| 16 | 29 | |
| 17 | 15 | |
| 18 | 107 | |
| 19 | 51 |
About Karin E. Smedby
Karin E. Smedby is a scholar working on Pathology and Forensic Medicine, Biological Psychiatry and Genetics, having authored 19 papers that have together received 538 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer Risks and Factors (4 papers). The work is most often cited by research in Genetics (164 citations), Pathology and Forensic Medicine (249 citations) and Transplantation (26 citations). Karin E. Smedby has collaborated with scholars based in Sweden, Denmark and United States. Frequent co-authors include Eva Baecklund, Johan Askling, Richard Rosenquist, Lesley‐Ann Sutton, Xavier Mariette, Mads Melbye, H Wilczek, Ellen T. Chang, C Brattström and Gustaf Edgren. Their work appears in journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and American Journal of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.